دورية أكاديمية
أعرض في EDS

Evaluation of the Appropriateness of Piperacillin-Tazobactam Prescription in Community-Acquired Pneumonia: A Tertiary-Center Experience.

التفاصيل البيبلوغرافية
العنوان: Evaluation of the Appropriateness of Piperacillin-Tazobactam Prescription in Community-Acquired Pneumonia: A Tertiary-Center Experience.
المؤلفون: Almajid A; Department of Internal Medicine, King Fahad Specialist Hospital, Dammam, SAU., Bazroon A; Department of Internal Medicine, King Fahad Specialist Hospital, Dammam, SAU., Albarbari H; Department of Internal Medicine, King Fahad Specialist Hospital, Dammam, SAU., Al-Awami HM; Department of Internal Medicine, King Fahad Specialist Hospital, Dammam, SAU., AlAhmed A; Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, SAU., Bakhurji OM; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Alharbi G; College of Medicine, Qassim University, Buraydah, SAU., Aldawood F; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., AlKhamis Z; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Alqarni M; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Alabdullah M; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Almutairi R; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
المصدر: Cureus [Cureus] 2023 Dec 31; Vol. 15 (12), pp. e51385. Date of Electronic Publication: 2023 Dec 31 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Background Antimicrobial resistance (AMR) has been designated a public health crisis by the World Health Organization. AMR can lead to escalated healthcare costs, higher mortality rates, increased morbidity, and more frequent hospitalizations. This study aimed to retrospectively evaluate the appropriateness of Tazocin prescription for community-acquired pneumonia (CAP). Methodology We conducted a retrospective analysis of patients aged ≥18 years who were admitted with a diagnosis of CAP and administered intravenous Tazocin between November 2021 and October 2022. The primary objective was to assess the appropriateness of Tazocin prescriptions in patients with CAP. Results A total of 39 patients with CAP were included, with a mean age of 61 ± 17.36 years. Overall, 24 (61%) patients were male. The rate of inappropriate prescriptions of Tazocin was 66.6%. The incidence of inappropriate Tazocin prescription varied significantly among different medical specialties, with the highest rate observed in the oncology-palliative specialty (90%; p = 0.033). Conclusions Our study affirms the inclination of physicians to prescribe Tazocin for CAP without justifiable indications and highlights the unwarranted use of Tazocin for CAP across various medical specialties. This is evidenced by the notably high rate of inappropriate empirical prescriptions.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Almajid et al.)
References: Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. (PMID: 16355321)
J Cardiothorac Surg. 2020 May 1;15(1):70. (PMID: 32357895)
Clin Infect Dis. 2022 Sep 29;75(6):1046-1053. (PMID: 35195716)
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. (PMID: 31573350)
Saudi Pharm J. 2020 Nov;28(11):1492-1498. (PMID: 33250656)
J Clin Oncol. 2013 Feb 20;31(6):794-810. (PMID: 23319691)
Curr Opin Crit Care. 2006 Apr;12(2):149-54. (PMID: 16543792)
Dig Dis Sci. 2016 Jun;61(6):1628-34. (PMID: 26715502)
Infect Drug Resist. 2012;5:17-21. (PMID: 22294859)
J Res Med Sci. 2018 Mar 27;23:21. (PMID: 29692818)
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S72-81. (PMID: 16355320)
Arch Intern Med. 2003 Mar 10;163(5):601-5. (PMID: 12622607)
Dig Dis Sci. 2011 Apr;56(4):1171-7. (PMID: 20931284)
Travel Med Infect Dis. 2010 Nov;8(6):377-87. (PMID: 21074495)
J Clin Oncol. 2013 Dec 1;31(34):4290-6. (PMID: 23630211)
فهرسة مساهمة: Keywords: antimicrobial resistance; antimicrobial stewardship; broad-spectrum; community-acquired pneumonia; inappropriate use; piperacillin-tazobactam; tazocin
تواريخ الأحداث: Date Created: 20240131 Latest Revision: 20240201
رمز التحديث: 20240201
مُعرف محوري في PubMed: PMC10825886
DOI: 10.7759/cureus.51385
PMID: 38292950
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.51385